Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Filings indexed 1,095 across all filing types
Latest filing 2016-03-17 Director's Dealing
Country US United States of America
Listing US NVAX

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2016-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2016-03-17 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the filing includes a press release announcing the company's financial results for the quarter ended December 31, 2015. The document itself does not contain detailed financial statements or substantive financial data but rather references an attached press release. The length of the document is 3433 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the rules, such a document that announces financial results but does not contain the full report should be classified as an Earnings Release (ER). The presence of a press release about quarterly financial results aligns with the definition of an Earnings Release.
2016-03-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.